-transparent.png){kind=logo}
68 patients with angina pectoris were treated 14 days with placebo and four weeks with 15 mg/die pindolol (Visken) in a double blind multicenter study. The patients were divided into two groups at random: group I received pindolol/placebo, group II pacebo/pindolol. Pindolol reduced in both groups significantly the number and intensity of angina pectoris attacks and the consumption of nitroglycerin capsules. There was no evidence for a rebound phenomenon after abrupt cessation of pindolol treatment. In the wash out period still a relevant antianginous effect of the beta-blocker could be observed. The oxygen demand of the myocardium was reduced by reduction of systolic blood pressure and heart rate whereas diastolic blood pressure remained unchanged. The tolerance of the preparation was good.
E Lang, and
P Fitscha, and
W Schiess
July 1971,
Deutsches medizinisches Journal,
E Lang, and
P Fitscha, and
W Schiess
May 1970,
Casopis lekaru ceskych,
E Lang, and
P Fitscha, and
W Schiess
May 1971,
L'union medicale du Canada,
E Lang, and
P Fitscha, and
W Schiess
January 1972,
Coeur et medecine interne,
E Lang, and
P Fitscha, and
W Schiess
April 1971,
Zeitschrift fur Kreislaufforschung,
E Lang, and
P Fitscha, and
W Schiess
January 1976,
Coeur et medecine interne,
E Lang, and
P Fitscha, and
W Schiess
July 1971,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E Lang, and
P Fitscha, and
W Schiess
December 1976,
Arquivos brasileiros de cardiologia,
E Lang, and
P Fitscha, and
W Schiess
February 1975,
Current therapeutic research, clinical and experimental,
E Lang, and
P Fitscha, and
W Schiess
January 1973,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
